Physician profile
Hunter G Paddock
NPI 1538510383
$2,666.58
in general payments reported to CMS, 2019-2025
12 companies · $506 in 2025
The $506 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $174 · 2022: $1,132 · 2023: $601 · 2024: $255 · 2025: $506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,304 · Travel and Lodging: $56.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,304.41 |
| Travel and Lodging | $56.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $905.80 | 2023-2025 | |
| Allergan, INC. | $416.29 | 2021-2022 | |
| Tela Bio, INC. | $337.90 | 2022 | |
| Integra Lifesciences Corporation | $253.97 | 2021-2023 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Axogen | $138.83 | 2025 | |
| Baxter Healthcare | $137.91 | 2022 | |
| Smith+Nephew, INC. | $134.17 | 2022 | |
| Sientra, INC. | $133.66 | 2022 | |
| Kerecis Limited | $61.25 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Musculoskeletal Transplant Foundation INC. | $56.72 | 2023 | |
| Genentech USA, INC. | $46.33 | 2024 | Xolair |
| Acera Surgical, INC. | $43.75 | 2024 | Restrata Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hunter Paddock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.